Integrating Healthcare Analytics to Improve Diabetes Management and Prevent Heart Attacks: A Data-Driven Approach

Integrating Healthcare Analytics to Improve Diabetes Management and Prevent Heart Attacks: A Data-Driven Approach | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Integrating Healthcare Analytics to Improve Diabetes Management and Prevent Heart Attacks: A Data-Driven Approach Naboshree Bhattacharya, Purushottam Kumar This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4310669/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Heart disease is a significant global health concern characterized by the heart's inability to adequately pump blood, leading to symptoms like weakness, difficulty breathing, and swollen feet. Detecting heart disease early is crucial, often relying on factors such as age, gender, and pulse rate analysis, as well as electrocardiogram screenings for irregular heartbeats. Risk factors include obesity, smoking, diabetes, high blood pressure, and unhealthy diets, with diabetic individuals facing elevated risks due to accelerated atherosclerosis and high blood sugar levels. Managing heart disease involves lifestyle modifications, medication adherence, and regular medical check-ups. Healthcare systems utilize data mining, machine learning, and clinical decision support systems to analyze extensive databases and predict conditions like heart disease, employing techniques such as supervised and unsupervised learning. Big data applications in healthcare, incorporating genomics data and electronic health records, provide insights into treatment effectiveness and real-time patient data analysis, facilitating personalized medicine and potentially saving lives. This research paper assesses the various components found in diabetes patients’ data to accurately forecast heart disease. It is identified by employing the Correlation-based Feature Subset Selection Technique with Best First Search, which is the most important characteristic for heart disease prediction. It has been discovered that age, gender, blood pressure diastolic, diabetes, smoking, obesity, diet, physical activity, stress, kind of chest pain, history of chest pain, troponin, ECG, and target are the most important factors for detecting heart disease. A variety of artificial intelligence methods are used and contrasted for cardiac disease, including logistic regression, K-nearest neighbor (K-NN), decision trees, random forests, and multilayer perceptrons (MLPs). Compared to using all the input features, K-NN with a subset of the features has the highest accuracy rate (80%). Heart disease Diabetes Predictive modelling Risk factors Artificial intelligence Healthcare Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 Figure 11 1.Introduction Diabetes mellitus is a multifaceted metabolic disorder characterized by chronic hyperglycaemia stemming from defects in insulin secretion, insulin action, or both. Insulin resistance stands out as a hallmark feature of type 2 diabetes mellitus (T2DM) (Kahn & Cooper, 2014), wherein target tissues exhibit reduced responsiveness to insulin, impairing glucose uptake, utilization, and lipid metabolism. Type 1 diabetes mellitus (T1DM) involves autoimmune destruction of pancreatic beta cells, resulting in absolute insulin deficiency. Risk factors for diabetes and its complications involve genetic, environmental, and lifestyle elements influencing disease development and progression (Censin et al., 2021 ; Zimmet et al., 2020; Hu et al., 2020; Chatterjee et al., 2020 ; Bellamy et al., 2009 ; Mancusi et al., 2020 ; Zheng et al., 2020; Vancampfort et al., 2020). It is a chronic metabolic disorder characterized by elevated blood sugar levels, poses a significant global health challenge. The rising prevalence of diabetes, estimated at 537 million in 2021 and projected to reach 783 million by 2045, highlights the growing concern and burden of this disease (International Diabetes Federation, 2021). Factors such as population growth, urbanization, unhealthy diets, and sedentary lifestyles contribute to the increasing incidence of diabetes worldwide. The pathophysiology of heart attacks, or myocardial infarctions (MI), entails a complex interaction of factors leading to the sudden interruption of blood flow to a part of the heart muscle. Coronary artery disease (CAD) stands as the primary cause, often resulting from atherosclerotic plaque buildup within the coronary arteries (Libby, 2021 ). The link between diabetes and heart attacks is a significant concern in both clinical and public health domains, given the elevated risk of cardiovascular complications among individuals with diabetes (American Diabetes Association, 2022 ). Epidemiological studies consistently demonstrate that individuals with diabetes face an escalated risk of heart attacks compared to those without diabetes (Emerging Risk Factors Collaboration, 2010 ). Diabetes contributes to endothelial dysfunction, inflammation, oxidative stress, and dyslipidaemia which collectively promote atherosclerosis progression and increase the risk of plaque rupture and thrombosis, precipitating heart attacks (Ridker et al., 2017). Healthcare analytics leverages advanced data analytics techniques to extract actionable insights from vast amounts of healthcare data. By harnessing the power of data, healthcare providers can gain deeper insights into disease patterns, identify high-risk individuals, tailor interventions, and optimize treatment strategies. The integration of healthcare analytics into diabetes management holds immense promise for enhancing the quality of care and reducing the incidence of diabetes-related complications, particularly heart attacks. Healthcare analytics platforms can provide comprehensive patient profiles, enabling healthcare providers to develop personalized care plans tailored to individual needs, preferences, and risk profiles. Healthcare analytics can facilitate proactive risk assessment and early intervention, thereby preventing the onset or progression of diabetes-related complications, including cardiovascular events like heart attacks. Predictive analytics models can identify patients at high risk of adverse outcomes, allowing healthcare providers to intervene pre-emptively with targeted interventions, medication adjustments, lifestyle modifications, and patient education initiatives. The integration of healthcare analytics represents a transformative paradigm shift in diabetes management and cardiovascular risk reduction, enabling personalized, proactive, and patient-centered care (Parikh et al., 2016 ; American Diabetes Association, 2020 ). Early detection and prevention of heart attacks in diabetic patients are crucial for reducing cardiovascular morbidity and mortality. It can play a vital role in identifying diabetic patients at high risk of developing heart attacks and guiding preventive interventions. Regular screening and monitoring of cardiovascular risk factors are essential for the early detection and prevention of heart attacks in diabetic patients. It can facilitate the implementation of evidence-based screening protocols and risk assessment tools to identify patients who may benefit from more aggressive risk factor management (American Heart Association, 2020 ; Piepoli et al., 2020 ). Patient education and self-management support are critical components of heart attack prevention in diabetic patients. Healthcare analytics can inform the development of personalized education programs and self-management interventions that empower patients to take an active role in their care (Barnason et al., 2017 ; Anderson et al., 2016 ). Integrating healthcare analytics into diabetes management and heart attack prevention poses significant data privacy and security challenges that must be addressed to ensure patient confidentiality and trust. Healthcare organizations must implement robust data governance frameworks to safeguard patient information from unauthorized access and breaches (Abouelmehdi et al., 2018 ). Compliance with data protection regulations is crucial for healthcare organizations leveraging analytics. Addressing data privacy and security concerns also involves fostering trust and transparency between healthcare providers and patients (Kalkman et al., 2019 ). Effective collaboration among healthcare providers, data scientists, and policymakers is essential for realizing the transformative potential of healthcare analytics in diabetes management and heart attack prevention. By working together to develop and implement data-driven solutions, these stakeholders can improve the quality, efficiency, and effectiveness of diabetes care, reduce the burden of cardiovascular complications, and ultimately improve the health and well-being of individuals and populations affected by these chronic diseases (Kruse et al., 2016 ; Bates et al., 2014 ; Raghupathi & Raghupathi, 2014 ; Rumsfeld et al., 2016; Reps et al., 2018). As we look to the future, the successful integration of healthcare analytics into diabetes management and heart attack prevention will require a concerted effort from all stakeholders in the healthcare ecosystem. This includes healthcare providers embracing data-driven approaches to care delivery, researchers advancing the frontiers of data science and medical knowledge, policymakers creating an enabling regulatory and funding environment, and patients actively engaging in their health and data sharing. Lastly the integration of healthcare analytics into diabetes management and heart attack prevention represents a major frontier in the quest to improve health outcomes and transform healthcare delivery. While significant challenges remain, the potential benefits are too great to ignore. By embracing data-driven approaches, fostering multidisciplinary collaboration, and investing in research and innovation, we can accelerate progress towards a future where diabetes and cardiovascular complications are more effectively prevented, detected, and treated, and where every patient receives the personalized, precision care they need to live longer, healthier lives. 2. Objective of the paper To investigate the potential of healthcare analytics in enhancing diabetes management and mitigating the risk of myocardial infarction by employing data-driven methodologies to stratify high-risk patients, personalize treatment interventions, and improve clinical outcomes. 3. Methodology The process of data pre-processing, synthetic dataset creation, and model training and evaluation is a crucial aspect of machine learning workflows. This structured approach ensures that the data is properly prepared and the models are rigorously evaluated to select the most suitable technique for a given task. The initial step in data pre-processing involves addressing class imbalance using techniques such as SMOTE (Synthetic Minority Over-sampling Technique). This ensures that the dataset has a balanced representation of different classes, preventing bias towards majority classes. Additionally, standardization is applied to scale the features, making them comparable across different ranges and enhancing model performance by reducing the impact of varying feature scales. Once the data is refined, a synthetic dataset is created by augmenting the original data through oversampling or other techniques. The purpose of generating a synthetic dataset is to provide a diverse set of examples for model training, improving the model's ability to generalize to unseen data. With the synthetic dataset prepared, the focus shifts to model training and evaluation. Three popular machine learning techniques are considered: Random Forest, K-Nearest Neighbors (KNN), and Logistic Regression. Each technique is trained on the synthetic dataset, and their performance is assessed using various evaluation metrics. Precision measures the proportion of true positive predictions among all positive predictions, indicating the model's ability to avoid false positives. Efficiency focuses on the computational efficiency of the model, considering factors such as training time and resource utilization. Recall, on the other hand, measures the proportion of true positive predictions among all actual positive instances, capturing the model's ability to identify positive cases. Finally, the F1 Score combines precision and recall, providing a balanced assessment of the model's overall performance. This systematic approach to data pre-processing, synthetic dataset creation, and model evaluation enables the selection of the optimal machine learning approach, ultimately leading to improved performance and more reliable results. 4. Data-Driven Approaches to Heart Attack Prediction 4.1 Data Collection and Analysis Heart disease stands as the leading cause of mortality across various racial groups in the United States, encompassing white individuals, American Indians and Alaska Natives, and African Americans. This widespread prevalence is attributed to several key risk factors, namely smoking, high blood pressure, diabetes, and high cholesterol. Alarmingly, more than half of all Americans (47%) exhibit at least one of these risk factors. Furthermore, additional significant markers for heart disease include diabetes, obesity (as indicated by a high body mass index), inadequate physical activity, and excessive alcohol consumption. In the realm of medicine, it is imperative to identify and address the variables that exert the most substantial influence on the development and progression of heart disease. This recognition is pivotal in formulating effective prevention and treatment strategies. The Behavioural Risk Factor Surveillance System (BRFSS) plays a crucial role in gathering vital health information about Americans through annual telephone surveys. This system, initially established in 1984 with data from 15 states, has expanded to encompass all 50 states, the District of Columbia, and three U.S. territories. With a staggering annual completion of over 400,000 adult interviews, the BRFSS stands as the world's largest continuously operating health survey system. The most recent dataset available is from 2023. Upon meticulous examination of the 2023 BRFSS dataset, which contains numerous variables directly or indirectly impacting heart disease, a decision was made to extract the most pertinent variables for further analysis and research. This process is essential for gaining insights into the factors contributing to heart disease and for developing targeted interventions to mitigate its impact. The original dataset, comprising nearly 300 variables, was streamlined to 40 variables, as stated earlier. This refined dataset serves as the basis for employing diverse machine learning techniques, specifically classifier models such as logistic regression, KNN, and random forest, alongside traditional exploratory data analysis (EDA). Notably, the variable "HadHeartAttack" is treated as binary, with "Yes" indicating the presence of heart illness and "No" signifying its absence. The imbalanced-learn library (imblearn) was utilized to implement the SMOTE (Synthetic Minority Over-sampling Technique) algorithm, following an assessment of the dataset to confirm its non-null status. Through oversampling the minority class, the SMOTE algorithm effectively mitigates class imbalance and improves the performance of machine learning models trained on imbalanced datasets. Next, the dataset undergoes division into training and testing sets using the train_test_split function from sklearn.model_selection, in preparation for the training and evaluation of machine learning models. The use of a random seed enables the reproducibility of the data split across multiple code executions, facilitating the assessment of the generalization capabilities of machine learning models to new data. Preprocessing serves as a crucial preparatory phase in machine learning, ensuring that datasets are suitably primed for model training and evaluation. One pivotal preprocessing technique aimed at ensuring equitable contribution of every feature to the analysis is standardization. Through the elimination of the mean and scaling to unit variance, the scikit-learn library's StandardScaler class offers a straightforward method for standardizing features. Subsequently, the training set undergoes the fit transform technique, which computes the mean and standard deviation for each feature and normalizes the features based on these metrics. To maintain consistency in the preprocessing stages, the same procedure is applied to the testing set. By ensuring uniformity in the preprocessing steps, standardization prevents features with larger scales from exerting disproportionate influence during the model training process. Currently, the Random Forest Classifier model is being employed following the completion of model training and the implementation of various techniques to standardize the data. This widely acclaimed ensemble learning approach entails the construction of numerous decision trees and the aggregation of the mean forecast from each individual tree or the mode of the classes. By setting np.random.seed(42), the random seed was established as 42 to ensure the reproducibility of results. This fixed random seed facilitates the attainment of consistent outcomes in the random initialization of model parameters, thereby enabling the model to anticipate events on previously unseen instances. This is achieved through the fitting of the data and the discernment of underlying patterns and relationships within it, empowering the model with the capability to make informed predictions. The model's performance was evaluated post-training using the score method on the testing data (X_test and y_test). This approach compares the predicted labels with the true labels in the testing set to ascertain the model's accuracy. The accuracy score represents the percentage of correctly identified instances out of all examples in the testing set. The accuracy score obtained from the Random Forest Classifier is 53%, signifying the model's ability to correctly classify 53% of instances within the testing set. Now, the K-Nearest Neighbors algorithm will be applied to the same dataset using the same trained model to assess its accuracy in comparison to the Random Forest Classifier. The accuracy score produced by the k-Nearest Neighbor Classifier is 89.4%, indicating its capability to correctly classify 89.4% of instances within the testing set. This accuracy surpasses that of the Random Forest Classifier, suggesting that the results yielded by the k-Nearest Neighbor model will likely be more precise than those obtained from the previous classifier. To ascertain if this algorithm has achieved the highest accuracy, the performance of another classifier, namely Logistic Regression, will be tested using the previously trained dataset. Upon assessing the accuracy scores of the three algorithms, it has been determined that the K-Nearest Neighbor Classifier provides the most accurate predictions for heart patient data. To reinforce this conclusion, a confusion matrix will be utilized. This evaluation tool is instrumental in the performance assessment of machine learning classification problems. Serving as a table, the confusion matrix enables a comprehensive examination of how well an algorithm, typically a classifier, performs on a set of test data with known real values. It goes beyond simple accuracy measurements by providing insights into the model's effectiveness in correctly and incorrectly identifying occurrences across multiple classes. Upon evaluating the accuracy derived from the generated confusion matrix, it was found to be nearly identical for all three algorithms. To resolve this parity, an additional metric, "Recall," has been incorporated into the matrix. Recall, also known as sensitivity or true positive rate, serves as a pivotal performance indicator for classification models. It represents the percentage of true positive predictions, i.e., accurately predicted positive cases, among all actual positive instances. This metric addresses the question of how many of the actual positive situations were correctly predicted as positive by the model. Recall holds particular significance in scenarios where the omission of an illness (false negative) in a medical diagnosis can have serious ramifications. The primary objective is to minimize false negatives. While a high recall rate may lead to some false positives, it signifies the model's effectiveness in identifying positive cases. Upon incorporating this additional aspect into our evaluation, it is evident that the KNN model demonstrates a superior ability to predict the data more accurately, exhibiting a notably high recall rate. After selecting the model, it is essential to examine the correlation between individuals with diabetes and heart disease. To achieve this, a correlation matrix has been constructed to provide insights into the likelihood of a person with diabetes also having heart disease. The correlation between diabetes and heart disease is a critical area of study, particularly considering the significant impact of these conditions on public health. Research indicates that over 70% of individuals over the age of 65 with diabetes are at risk of succumbing to some form of heart disease or stroke. Furthermore, patients with diabetes experience increased mortality following a myocardial infarction and have a poorer long-term prognosis with coronary artery disease. These findings underscore the intricate relationship between diabetes and cardiovascular health, emphasizing the need for comprehensive understanding and effective management of these conditions. The correlation matrix serves as a valuable tool in elucidating the relationship between diabetes and heart disease, shedding light on the percentage likelihood of an individual with diabetes also being affected by heart disease. This analysis is crucial for informing targeted interventions and healthcare strategies aimed at addressing the complex interplay between diabetes and heart disease. According to the constructed correlation matrix, there is an approximately 17% association between diabetes and heart disease. While a positive correlation is evident, it is not particularly robust. Consequently, it can be inferred that an individual with diabetes faces a 17% probability of also being affected by heart disease. The scatter plot graph depicted above illustrates the relationship between heart disease and diabetes. As the presence of diabetes increases (moving up along the y-axis), the incidence of heart disease also increases (moving from left to right). Understanding the correlation between diabetes and heart disease is crucial, given the significant health implications associated with these conditions. Research has shown that individuals with diabetes are at a heightened risk of developing cardiovascular complications, emphasizing the importance of comprehensively examining the relationship between these two health concerns. 5. Conclusion The analysis conducted underscores the pervasive threat of heart disease across diverse racial groups in the United States, with risk factors including smoking, high blood pressure, diabetes, high cholesterol, obesity, sedentary lifestyles, and excessive alcohol consumption. Leveraging data from the Behavioural Risk Factor Surveillance System (BRFSS), we have employed machine learning techniques like Random Forest, k-Nearest Neighbors (KNN), and Logistic Regression to predict heart disease occurrences. Notably, KNN emerges as the most accurate classifier among the models tested, demonstrating superior predictive capabilities. Additional insights garnered from confusion matrices and recall rates inform the selection of the most effective classification model. A correlation analysis reveals a moderate link of 17% between diabetes and heart disease, suggesting a nuanced understanding of their relationship. Visual representations, such as scatter plots, further elucidate the correlation between diabetes and heart disease, indicating a propensity for heart disease with increasing diabetes prevalence. These findings highlight the importance of leveraging advanced analytics to combat heart disease effectively, enabling targeted interventions and preventive strategies to mitigate its impact. 6. Future Perspectives of the Study The future perspective of this paper lies in the continued advancement and integration of healthcare analytics into routine clinical practice. As technology evolves and data analytics capabilities expand, the potential for even more precise risk assessment, personalized treatment strategies, and proactive interventions in diabetes management will grow. Additionally, the incorporation of artificial intelligence and machine learning algorithms can further enhance predictive modeling and decision-making processes, leading to more effective and efficient healthcare delivery. Furthermore, the integration of wearable devices, remote monitoring technologies, and telemedicine solutions can facilitate real-time data collection and monitoring, enabling continuous feedback and personalized care for individuals with diabetes. Collaborations between healthcare providers, data scientists, and technology experts will be essential in driving innovation and optimizing the use of healthcare analytics for improved patient outcomes. In the future, the focus may shift towards developing comprehensive, integrated healthcare analytics platforms that seamlessly connect various data sources, streamline workflows, and empower both patients and healthcare providers with actionable insights. This holistic approach to data-driven healthcare management has the potential to revolutionize chronic disease care, enhance preventive measures, and ultimately contribute to better health outcomes for individuals with diabetes and other chronic conditions. Declarations It is being dispatched for exclusive consideration by the Journal and has not been sent elsewhere for publication. Funding: No funding was received for conducting this study. Competing interests: The authors have no competing interests to declare that are relevant to the content of this article. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Availability of data and materials: Not applicable. Code availability: Not applicable. References Abouelmehdi, K., Beni-Hessane, A., & Khaloufi, H. (2018). Big healthcare data: Preserving security and privacy. Journal of Big Data, 5(1), 1-18. https://doi.org/10.1186/s40537-017-0110-7 Alotaibi, Y. K., & Federico, F. (2017). The impact of health information technology on patient safety. Saudi Medical Journal, 38(12), 1173-1180. https://doi.org/10.15537/smj.2017.12.20631 American College of Cardiology. (2021). Guideline-Directed Medical Therapy for Secondary Prevention of Myocardial Infarction. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2021/07/23/14/47/guideline-directed-medical-therapy-for-secondary American Diabetes Association. (2020). Cardiovascular disease and risk management: Standards of medical care in diabetes—2020. Diabetes Care, 43(Supplement 1), S111-S134. https://doi.org/10.2337/dc20-S010 American Diabetes Association. (2022). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement 1), S17–S38. American Diabetes Association. (2022). Standards of medical care in diabetes—2022. Diabetes Care, 45(Supplement 1), S1-S270. https://doi.org/10.2337/dc22-Sint American Heart Association. (2020). 2020 AHA guidelines for CPR and ECC. https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines American Heart Association. (2021). Lifestyle changes for heart attack prevention. https://www.heart.org/en/health-topics/heart-attack/lifestyle-changes-for-heart-attack-prevention American Heart Association. (2022). Life's simple 7: Manage blood pressure. https://www.heart.org/en/healthy-living/healthy-lifestyle/my-life-check--lifes-simple-7/ls7--manage-blood-pressure Anderson, L., Brown, J. P., Clark, A. M., Dalal, H., Rossau, H. K., Bridges, C., & Taylor, R. S. (2016). Patient education in the management of coronary heart disease. Cochrane Database of Systematic Reviews, 2016(6), CD008895. https://doi.org/10.1002/14651858.CD008895.pub3 Anderson, L., Oldridge, N., Thompson, D. R., Zwisler, A. D., Rees, K., Martin, N., ... & Taylor, R. S. (2016). Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews, 2016(1), CD001800. Barnason, S., White-Williams, C., Rossi, L. P., Centeno, M., Crabbe, D. L., Lee, K. S., McCabe, N., Nauser, J., Schulz, P., Stamp, K., & Wood, K. (2017). Evidence for therapeutic patient education interventions to promote cardiovascular patient self-management: A scientific statement for healthcare professionals from the American Heart Association. Circulation: Cardiovascular Quality and Outcomes, 10(6), e000025. https://doi.org/10.1161/HCQ.0000000000000025 Barnason, S., Zimmerman, L., Young, L., & Schulz, P. (2017). Patient recovery after acute coronary syndrome: integrating the women's recovery from myocardial inf Bates, D. W., Saria, S., Ohno-Machado, L., Shah, A., & Escobar, G. (2014). Big data in health care: Using analytics to identify and manage high-risk and high-cost patients. Health Affairs, 33(7), 1123-1131. https://doi.org/10.1377/hlthaff.2014.0041 Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet, 373(9677), 1773-1779. https://doi.org/10.1016/S0140-6736(09)60731-5 Benson, T., & Grieve, G. (2021). Principles of health interoperability: SNOMED CT, HL7 and FHIR. Springer Nature. Bhatt, D. L., & Mehta, C. (2020). Atherosclerosis in Diabetes Mellitus. In Diabetes Mellitus and Cardiovascular Disease (pp. 23-34). Springer, Cham. Bhatt, D. L., & Mehta, C. (2020). Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy. American Journal of Medicine, 133(8), 918-925. Bhatt, D. L., & Mehta, C. (2020). Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 36(5), 648-656. https://doi.org/10.1016/j.cjca.2019.12.033 Bornfeldt, K. E., & Tabas, I. (2011). Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism, 14(5), 575-585. https://doi.org/10.1016/j.cmet.2011.07.015 Braunstein, M. L. (2018). Health informatics on FHIR: How HL7's new API is transforming healthcare. Springer. Centers for Disease Control and Prevention. (2021). Heart disease prevention. https://www.cdc.gov/heartdisease/prevention.htm Censin, J. C., Peters, S. A. E., Bovijn, J., Ferreira, T., Pulit, S. L., Mägi, R., Mahajan, A., Holmes, M. V., & Lindgren, C. M. (2021). Causal relationships between obesity and the leading causes of death in women and men. PLoS Genetics, 15(10), e1008405. https://doi.org/10.1371/journal.pgen.1008405 Chatterjee, S., Khunti, K., & Davies, M. J. (2020). Achieving glycaemic control with concentrated insulin in patients with type 2 diabetes. Drugs, 80(2), 119-129. https://doi.org/10.1007/s40265-019-01249-z Chow, C. K., Nguyen, T. N., Marschner, S., Diaz, R., Rahman, O., Avezum, A., Lear, S. A., Teo, K., Lanas, F., Yusoff, K., Yusuf, S., & Anand, S. S. (2020). Lifestyle and socioeconomic determinants of cardiovascular disease in South Asia: The PURE study. European Heart Journal, 41(33), 3163-3171. https://doi.org/10.1093/eurheartj/ehaa384 Chow, C. K., Teo, K. K., Rangarajan, S., Islam, S., Gupta, R., Avezum, A., ... & Yusuf, S. (2020). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Jama, 310(9), 959-968. Contreras, I., & Vehi, J. (2018). Artificial intelligence for diabetes management and decision support: Literature review. Journal of Medical Internet Research, 20(5), e10775. https://doi.org/10.2196/10775 Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., Huikuri, H. V., Johansson, I., Jüni, P., Lettino, M., Marx, N., Mellbin, L. G., Östgren, C. J., Rocca, B., Roffi, M., ... ESC Scientific Document Group. (2020). 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal, 41(2), 255-323. https://doi.org/10.1093/eurheartj/ehz486 Coventry, L., & Branley, D. (2018). Cybersecurity in healthcare: A narrative review of trends, threats and ways forward. Maturitas, 113, 48-52. https://doi.org/10.1016/j.maturitas.2018.04.008 Dagliati, A., Marini, S., Sacchi, L., Cogni, G., Teliti, M., Tibollo, V., De Cata, P., Chiovato, L., & Bellazzi, R. (2018). Machine learning methods to predict diabetes complications. Journal of Diabetes Science and Technology, 12(2), 295-302. https://doi.org/10.1177/1932296817706375 Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11(2), 98-107. https://doi.org/10.1038/nri2925 Emerging Risk Factors Collaboration. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet, 375(9733), 2215-2222. https://doi.org/10.1016/S0140-6736(10)60484-9 Feldman, B., Martin, E. M., & Skotnes, T. (2016). Big data in healthcare hype and hope. Dr. Bonnie 360. https://www.west-info.eu/files/big-data-in-healthcare.pdf Frangogiannis, N. G. (2019). The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology, 16(1), 17-36. https://doi.org/10.1038/s41569-019-0185-2 Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1046-e1081. https://doi.org/10.1161/CIR.0000000000000624 Hripcsak, G., Ryan, P. B., Duke, J. D., Shah, N. H., Park, R. W., Huser, V., Suchard, M. A., Schuemie, M. J., DeFalco, F. J., Perotte, A., Banda, J. M., Reich, C. G., Schilling, L. M., Matheny, M. E., Meeker, D., Pratt, N., & Madigan, D. (2015). Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Studies in Health Technology and Informatics, 216, 574-578. https://doi.org/10.3233/978-1-61499-564-7-574 Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., & McKinney, E. F. (2020). From big data to precision medicine. Frontiers in Medicine, 6, 34. https://doi.org/10.3389/fmed.2019.00034 Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017). Artificial intelligence in healthcare: Past, present and future. Stroke and Vascular Neurology, 2(4), 230-243. https://doi.org/10.1136/svn-2017-000101 Kalkman, S., van Delden, J., Banerjee, A., Tyl, B., Mostert, M., & van Thiel, G. (2019). Patients' and public views and attitudes towards the sharing of health data for research: A narrative review of the empirical evidence. Journal of Medical Ethics, 0, 1-11. https://doi.org/10.1136/medethics-2019-105651 Kaplan, B. (2016). How should health data be used? Privacy, secondary use, and big data sales. Cambridge Quarterly of Healthcare Ethics, 25(2), 312-329. https://doi.org/10.1017/S0963180115000614 Kaur, G., & Sharma, A. (2021). Diabetic Cardiomyopathy: Mechanisms, Diagnosis, and Treatment. International Journal of Molecular Sciences, 22(16), 9006. https://doi.org/10.3390/ijms22169006 Kruse, C. S., Goswamy, R., Raval, Y., & Marawi, S. (2016). Challenges and opportunities of big data in health care: A systematic review. JMIR Medical Informatics, 4(4), e38. https://doi.org/10.2196/medinform.5359 Lehne, M., Sass, J., Essenwanger, A., Schepers, J., & Thun, S. (2019). Why digital medicine depends on interoperability. NPJ Digital Medicine, 2, 79. https://doi.org/10.1038/s41746-019-0158-1 Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524-533. https://doi.org/10.1038/s41586-021-03392-8 Lysaght, T., Lim, H. Y., Xafis, V., & Ngiam, K. Y. (2019). AI-assisted decision-making in healthcare: The application of an ethics framework for big data in health and research. Asian Bioethics Review, 11(3), 299-314. https://doi.org/10.1007/s41649-019-00096-0 Mancusi, C., Izzo, R., di Gioia, G., Losi, M. A., Barbato, E., & Morisco, C. (2020). Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Pressure & Cardiovascular Prevention, 27(6), 515-526. https://doi.org/10.1007/s40292-020-00408-8 Mandel, J. C., Kreda, D. A., Mandl, K. D., Kohane, I. S., & Ramoni, R. B. (2016). SMART on FHIR: Mandel, J. C., Kreda, D. A., Mandl, K. D., Kohane, I. S., & Ramoni, R. B. (2016). SMART on FHIR: A standards-based, interoperable apps platform for electronic health records. Journal of the American Medical Informatics Association, 23(5), 899-908. https://doi.org/10.1093/jamia/ocv189 Murdoch, T. B., & Detsky, A. S. (2013). The inevitable application of big data to health care. JAMA, 309(13), 1351-1352. https://doi.org/10.1001/jama.2013.393 Parikh, R. B., Kakad, M., & Bates, D. W. (2016). Integrating predictive analytics into high-value care: The dawn of precision delivery. JAMA, 315(7), 651-652. https://doi.org/10.1001/jama.2015.19417 Piepoli, M. F., Hoes, A. W., Brotons, C., Hobbs, R. F. D., & Corra, U. (2020). Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Journal of General Practice, 24(1), 51-56. https://doi.org/10.1080/13814788.2017.1398320 Raghupathi, W., & Raghupathi, V. (2014). Big data analytics in healthcare: Promise and potential. Health Information Science and Systems, 2(1), 3. https://doi.org/10.1186/2047-2501-2-3 Ristevski, B., & Chen, M. (2018). Big data analytics in medicine and healthcare. Journal of Integrative Bioinformatics, 15(3), 20170030. https://doi.org/10.1515/jib-2017-0030 Shickel, B., Tighe, P. J., Bihorac, A., & Rashidi, P. (2018). Deep EHR: A survey of recent advances in deep learning techniques for electronic health record (EHR) analysis. IEEE Journal of Biomedical and Health Informatics, 22(5), 1589-1604. https://doi.org/10.1109/JBHI.2017.2767063 Siegel, E. R., Roybal, M. M., & Bennett, R. E. (2018). Harnessing the power of data in health. Stanford Medicine 2018 Health Trends Report. https://med.stanford.edu/content/dam/sm/sm-news/documents/StanfordMedicineHealthTrendsWhitePaper2018.pdf Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020). An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Digital Medicine, 3, 17. https://doi.org/10.1038/s41746-020-0221-y Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: A high-risk state for diabetes development. Lancet, 379(9833), 2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9 Verma, S., & Hussain, M. E. (2017). Obesity and diabetes: An update. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11(1), 73-79. https://doi.org/10.1016/j.dsx.2016.06.017 World Health Organization. (2021). Cardiovascular diseases. https://www.who.int/health-topics/cardiovascular-diseases World Health Organization. (2021). Diabetes. https://www.who.int/health-topics/diabetes Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), 88-98. https://doi.org/10.1038/nrendo.2017.151 Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4310669","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":297798836,"identity":"7458a915-8a15-4fd8-84fe-f118da10a6be","order_by":0,"name":"Naboshree Bhattacharya","email":"data:image/png;base64,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","orcid":"","institution":"Amity University","correspondingAuthor":true,"prefix":"","firstName":"Naboshree","middleName":"","lastName":"Bhattacharya","suffix":""},{"id":297798838,"identity":"9adf061b-03ee-4c40-a30b-17a8c8bf7be2","order_by":1,"name":"Purushottam Kumar","email":"","orcid":"","institution":"Amity University","correspondingAuthor":false,"prefix":"","firstName":"Purushottam","middleName":"","lastName":"Kumar","suffix":""}],"badges":[],"createdAt":"2024-04-23 08:57:51","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4310669/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4310669/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":56196693,"identity":"7fe8415c-60e6-4b54-9860-16867644717a","added_by":"auto","created_at":"2024-05-09 18:11:51","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":125220,"visible":true,"origin":"","legend":"\u003cp\u003eFlow Chart of Structural Approach\u003c/p\u003e","description":"","filename":"floatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/8b42196e6202786341ee92b0.png"},{"id":56196720,"identity":"8bf711cb-04c3-48d1-8d48-18a8667a2780","added_by":"auto","created_at":"2024-05-09 18:12:29","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":52472,"visible":true,"origin":"","legend":"\u003cp\u003eTypes of data\u003c/p\u003e","description":"","filename":"floatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/b1c8796d561b63e8511547fb.png"},{"id":56196725,"identity":"8ca654aa-7030-4792-abda-e9b09d2ca5bd","added_by":"auto","created_at":"2024-05-09 18:12:40","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":11812,"visible":true,"origin":"","legend":"\u003cp\u003eSynthetic Minority Over-sampling Technique.\u003c/p\u003e","description":"","filename":"floatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/f2fc49c2df2f00a68a826049.png"},{"id":56196710,"identity":"fda5b448-0d4a-4ec9-aa15-187c2d40eb6e","added_by":"auto","created_at":"2024-05-09 18:11:55","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":11183,"visible":true,"origin":"","legend":"\u003cp\u003ePre-processing data set.\u003c/p\u003e","description":"","filename":"floatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/2a84cce832f9bd20591dc858.png"},{"id":56196657,"identity":"cde7baf1-c7ae-43ab-bfaa-beee947daac8","added_by":"auto","created_at":"2024-05-09 18:11:47","extension":"png","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":13249,"visible":true,"origin":"","legend":"\u003cp\u003eStandard Scaler preprocessing Technique.\u003c/p\u003e","description":"","filename":"floatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/26ed0645729188c9ee3adb62.png"},{"id":56196718,"identity":"d4b4bf48-2357-487a-b2ff-be86f2d8d2d4","added_by":"auto","created_at":"2024-05-09 18:12:27","extension":"png","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":22673,"visible":true,"origin":"","legend":"\u003cp\u003eRandom Forest Classifier.\u003c/p\u003e","description":"","filename":"floatimage6.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/d78fe08d612c555ed2fdfd37.png"},{"id":56196727,"identity":"ef4dfb8c-ed0d-4519-93a5-a1ecb262cdbf","added_by":"auto","created_at":"2024-05-09 18:12:44","extension":"png","order_by":7,"title":"Figure 7","display":"","copyAsset":false,"role":"figure","size":14802,"visible":true,"origin":"","legend":"\u003cp\u003eKNN Techniques.\u003c/p\u003e","description":"","filename":"floatimage7.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/02b001bd0d3b6e9aaca4cc0c.png"},{"id":56196721,"identity":"732206f6-a486-4138-b06b-c1cd47ce249c","added_by":"auto","created_at":"2024-05-09 18:12:32","extension":"png","order_by":8,"title":"Figure 8","display":"","copyAsset":false,"role":"figure","size":14507,"visible":true,"origin":"","legend":"\u003cp\u003eLogistic Regression Technique.\u003c/p\u003e","description":"","filename":"floatimage8.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/226dcfc8b0fa4424e4c01d45.png"},{"id":56197033,"identity":"1fac92eb-6c2c-4195-a254-1ea3f18339d5","added_by":"auto","created_at":"2024-05-09 18:20:37","extension":"png","order_by":9,"title":"Figure 9","display":"","copyAsset":false,"role":"figure","size":44973,"visible":true,"origin":"","legend":"\u003cp\u003eConfusion matrix.\u003c/p\u003e","description":"","filename":"floatimage9.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/8bb3316a1dc213b7fd95ad00.png"},{"id":56197032,"identity":"6360a436-024a-4ba1-87ca-f6fe099670b1","added_by":"auto","created_at":"2024-05-09 18:20:28","extension":"png","order_by":10,"title":"Figure 10","display":"","copyAsset":false,"role":"figure","size":305125,"visible":true,"origin":"","legend":"\u003cp\u003eCorrelation between Diabetes and Heart Disease.\u003c/p\u003e","description":"","filename":"floatimage10.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/f674ab77c7e720cd55d05c04.png"},{"id":56196723,"identity":"b2dfc575-7a61-40db-87e8-8eac9ace9202","added_by":"auto","created_at":"2024-05-09 18:12:36","extension":"png","order_by":11,"title":"Figure 11","display":"","copyAsset":false,"role":"figure","size":32309,"visible":true,"origin":"","legend":"\u003cp\u003eLine graph of Diabetic and Heart Disease.\u003c/p\u003e","description":"","filename":"floatimage11.png","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/393f998e6c309e901c65cfb1.png"},{"id":56715913,"identity":"ae33524c-00a1-43bd-b085-d7f44dee1248","added_by":"auto","created_at":"2024-05-18 19:08:32","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":878760,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4310669/v1/eb83ae6d-2ac8-4740-8382-646d2d2c0895.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Integrating Healthcare Analytics to Improve Diabetes Management and Prevent Heart Attacks: A Data-Driven Approach","fulltext":[{"header":"1.Introduction","content":"\u003cp\u003eDiabetes mellitus is a multifaceted metabolic disorder characterized by chronic hyperglycaemia stemming from defects in insulin secretion, insulin action, or both. Insulin resistance stands out as a hallmark feature of type 2 diabetes mellitus (T2DM) (Kahn \u0026amp; Cooper, 2014), wherein target tissues exhibit reduced responsiveness to insulin, impairing glucose uptake, utilization, and lipid metabolism. Type 1 diabetes mellitus (T1DM) involves autoimmune destruction of pancreatic beta cells, resulting in absolute insulin deficiency. Risk factors for diabetes and its complications involve genetic, environmental, and lifestyle elements influencing disease development and progression (Censin et al., \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e2021\u003c/span\u003e; Zimmet et al., 2020; Hu et al., 2020; Chatterjee et al., \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e2020\u003c/span\u003e; Bellamy et al., \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e2009\u003c/span\u003e; Mancusi et al., \u003cspan citationid=\"CR46\" class=\"CitationRef\"\u003e2020\u003c/span\u003e; Zheng et al., 2020; Vancampfort et al., 2020). It is a chronic metabolic disorder characterized by elevated blood sugar levels, poses a significant global health challenge. The rising prevalence of diabetes, estimated at 537\u0026nbsp;million in 2021 and projected to reach 783\u0026nbsp;million by 2045, highlights the growing concern and burden of this disease (International Diabetes Federation, 2021). Factors such as population growth, urbanization, unhealthy diets, and sedentary lifestyles contribute to the increasing incidence of diabetes worldwide.\u003c/p\u003e \u003cp\u003eThe pathophysiology of heart attacks, or myocardial infarctions (MI), entails a complex interaction of factors leading to the sudden interruption of blood flow to a part of the heart muscle. Coronary artery disease (CAD) stands as the primary cause, often resulting from atherosclerotic plaque buildup within the coronary arteries (Libby, \u003cspan citationid=\"CR44\" class=\"CitationRef\"\u003e2021\u003c/span\u003e). The link between diabetes and heart attacks is a significant concern in both clinical and public health domains, given the elevated risk of cardiovascular complications among individuals with diabetes (American Diabetes Association, \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2022\u003c/span\u003e). Epidemiological studies consistently demonstrate that individuals with diabetes face an escalated risk of heart attacks compared to those without diabetes (Emerging Risk Factors Collaboration, \u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e2010\u003c/span\u003e). Diabetes contributes to endothelial dysfunction, inflammation, oxidative stress, and dyslipidaemia which collectively promote atherosclerosis progression and increase the risk of plaque rupture and thrombosis, precipitating heart attacks (Ridker et al., 2017).\u003c/p\u003e \u003cp\u003eHealthcare analytics leverages advanced data analytics techniques to extract actionable insights from vast amounts of healthcare data. By harnessing the power of data, healthcare providers can gain deeper insights into disease patterns, identify high-risk individuals, tailor interventions, and optimize treatment strategies. The integration of healthcare analytics into diabetes management holds immense promise for enhancing the quality of care and reducing the incidence of diabetes-related complications, particularly heart attacks. Healthcare analytics platforms can provide comprehensive patient profiles, enabling healthcare providers to develop personalized care plans tailored to individual needs, preferences, and risk profiles.\u003c/p\u003e \u003cp\u003eHealthcare analytics can facilitate proactive risk assessment and early intervention, thereby preventing the onset or progression of diabetes-related complications, including cardiovascular events like heart attacks. Predictive analytics models can identify patients at high risk of adverse outcomes, allowing healthcare providers to intervene pre-emptively with targeted interventions, medication adjustments, lifestyle modifications, and patient education initiatives. The integration of healthcare analytics represents a transformative paradigm shift in diabetes management and cardiovascular risk reduction, enabling personalized, proactive, and patient-centered care (Parikh et al., \u003cspan citationid=\"CR49\" class=\"CitationRef\"\u003e2016\u003c/span\u003e; American Diabetes Association, \u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e2020\u003c/span\u003e). Early detection and prevention of heart attacks in diabetic patients are crucial for reducing cardiovascular morbidity and mortality. It can play a vital role in identifying diabetic patients at high risk of developing heart attacks and guiding preventive interventions. Regular screening and monitoring of cardiovascular risk factors are essential for the early detection and prevention of heart attacks in diabetic patients. It can facilitate the implementation of evidence-based screening protocols and risk assessment tools to identify patients who may benefit from more aggressive risk factor management (American Heart Association, \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e2020\u003c/span\u003e; Piepoli et al., \u003cspan citationid=\"CR50\" class=\"CitationRef\"\u003e2020\u003c/span\u003e).\u003c/p\u003e \u003cp\u003ePatient education and self-management support are critical components of heart attack prevention in diabetic patients. Healthcare analytics can inform the development of personalized education programs and self-management interventions that empower patients to take an active role in their care (Barnason et al., \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e2017\u003c/span\u003e; Anderson et al., \u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e2016\u003c/span\u003e). Integrating healthcare analytics into diabetes management and heart attack prevention poses significant data privacy and security challenges that must be addressed to ensure patient confidentiality and trust. Healthcare organizations must implement robust data governance frameworks to safeguard patient information from unauthorized access and breaches (Abouelmehdi et al., \u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e2018\u003c/span\u003e). Compliance with data protection regulations is crucial for healthcare organizations leveraging analytics. Addressing data privacy and security concerns also involves fostering trust and transparency between healthcare providers and patients (Kalkman et al., \u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e2019\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eEffective collaboration among healthcare providers, data scientists, and policymakers is essential for realizing the transformative potential of healthcare analytics in diabetes management and heart attack prevention. By working together to develop and implement data-driven solutions, these stakeholders can improve the quality, efficiency, and effectiveness of diabetes care, reduce the burden of cardiovascular complications, and ultimately improve the health and well-being of individuals and populations affected by these chronic diseases (Kruse et al., \u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e2016\u003c/span\u003e; Bates et al., \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e2014\u003c/span\u003e; Raghupathi \u0026amp; Raghupathi, \u003cspan citationid=\"CR51\" class=\"CitationRef\"\u003e2014\u003c/span\u003e; Rumsfeld et al., 2016; Reps et al., 2018).\u003c/p\u003e \u003cp\u003eAs we look to the future, the successful integration of healthcare analytics into diabetes management and heart attack prevention will require a concerted effort from all stakeholders in the healthcare ecosystem. This includes healthcare providers embracing data-driven approaches to care delivery, researchers advancing the frontiers of data science and medical knowledge, policymakers creating an enabling regulatory and funding environment, and patients actively engaging in their health and data sharing.\u003c/p\u003e \u003cp\u003eLastly the integration of healthcare analytics into diabetes management and heart attack prevention represents a major frontier in the quest to improve health outcomes and transform healthcare delivery. While significant challenges remain, the potential benefits are too great to ignore. By embracing data-driven approaches, fostering multidisciplinary collaboration, and investing in research and innovation, we can accelerate progress towards a future where diabetes and cardiovascular complications are more effectively prevented, detected, and treated, and where every patient receives the personalized, precision care they need to live longer, healthier lives.\u003c/p\u003e"},{"header":"2. Objective of the paper","content":"\u003cp\u003eTo investigate the potential of healthcare analytics in enhancing diabetes management and mitigating the risk of myocardial infarction by employing data-driven methodologies to stratify high-risk patients, personalize treatment interventions, and improve clinical outcomes.\u003c/p\u003e"},{"header":"3. Methodology","content":"\u003cp\u003eThe process of data pre-processing, synthetic dataset creation, and model training and evaluation is a crucial aspect of machine learning workflows. This structured approach ensures that the data is properly prepared and the models are rigorously evaluated to select the most suitable technique for a given task.\u003c/p\u003e \u003cp\u003eThe initial step in data pre-processing involves addressing class imbalance using techniques such as SMOTE (Synthetic Minority Over-sampling Technique). This ensures that the dataset has a balanced representation of different classes, preventing bias towards majority classes. Additionally, standardization is applied to scale the features, making them comparable across different ranges and enhancing model performance by reducing the impact of varying feature scales.\u003c/p\u003e \u003cp\u003eOnce the data is refined, a synthetic dataset is created by augmenting the original data through oversampling or other techniques. The purpose of generating a synthetic dataset is to provide a diverse set of examples for model training, improving the model's ability to generalize to unseen data.\u003c/p\u003e \u003cp\u003eWith the synthetic dataset prepared, the focus shifts to model training and evaluation. Three popular machine learning techniques are considered: Random Forest, K-Nearest Neighbors (KNN), and Logistic Regression. Each technique is trained on the synthetic dataset, and their performance is assessed using various evaluation metrics. Precision measures the proportion of true positive predictions among all positive predictions, indicating the model's ability to avoid false positives. Efficiency focuses on the computational efficiency of the model, considering factors such as training time and resource utilization. Recall, on the other hand, measures the proportion of true positive predictions among all actual positive instances, capturing the model's ability to identify positive cases. Finally, the F1 Score combines precision and recall, providing a balanced assessment of the model's overall performance.\u003c/p\u003e \u003cp\u003eThis systematic approach to data pre-processing, synthetic dataset creation, and model evaluation enables the selection of the optimal machine learning approach, ultimately leading to improved performance and more reliable results.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e"},{"header":"4. Data-Driven Approaches to Heart Attack Prediction","content":"\u003cp\u003e\u003cstrong\u003e4.1 Data Collection and Analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eHeart disease stands as the leading cause of mortality across various racial groups in the United States, encompassing white individuals, American Indians and Alaska Natives, and African Americans. This widespread prevalence is attributed to several key risk factors, namely smoking, high blood pressure, diabetes, and high cholesterol. Alarmingly, more than half of all Americans (47%) exhibit at least one of these risk factors. Furthermore, additional significant markers for heart disease include diabetes, obesity (as indicated by a high body mass index), inadequate physical activity, and excessive alcohol consumption.\u003c/p\u003e\n\u003cp\u003eIn the realm of medicine, it is imperative to identify and address the variables that exert the most substantial influence on the development and progression of heart disease. This recognition is pivotal in formulating effective prevention and treatment strategies.\u003c/p\u003e\n\u003cp\u003eThe Behavioural Risk Factor Surveillance System (BRFSS) plays a crucial role in gathering vital health information about Americans through annual telephone surveys. This system, initially established in 1984 with data from 15 states, has expanded to encompass all 50 states, the District of Columbia, and three U.S. territories. With a staggering annual completion of over 400,000 adult interviews, the BRFSS stands as the world\u0026apos;s largest continuously operating health survey system. The most recent dataset available is from 2023.\u003c/p\u003e\n\u003cp\u003eUpon meticulous examination of the 2023 BRFSS dataset, which contains numerous variables directly or indirectly impacting heart disease, a decision was made to extract the most pertinent variables for further analysis and research. This process is essential for gaining insights into the factors contributing to heart disease and for developing targeted interventions to mitigate its impact.\u003c/p\u003e\n\u003cp\u003eThe original dataset, comprising nearly 300 variables, was streamlined to 40 variables, as stated earlier. This refined dataset serves as the basis for employing diverse machine learning techniques, specifically classifier models such as logistic regression, KNN, and random forest, alongside traditional exploratory data analysis (EDA). Notably, the variable \u0026quot;HadHeartAttack\u0026quot; is treated as binary, with \u0026quot;Yes\u0026quot; indicating the presence of heart illness and \u0026quot;No\u0026quot; signifying its absence.\u003c/p\u003e\n\u003cp\u003eThe imbalanced-learn library (imblearn) was utilized to implement the SMOTE (Synthetic Minority Over-sampling Technique) algorithm, following an assessment of the dataset to confirm its non-null status. Through oversampling the minority class, the SMOTE algorithm effectively mitigates class imbalance and improves the performance of machine learning models trained on imbalanced datasets.\u003c/p\u003e\n\u003cp\u003eNext, the dataset undergoes division into training and testing sets using the train_test_split function from sklearn.model_selection, in preparation for the training and evaluation of machine learning models. The use of a random seed enables the reproducibility of the data split across multiple code executions, facilitating the assessment of the generalization capabilities of machine learning models to new data.\u003c/p\u003e\n\u003cp\u003ePreprocessing serves as a crucial preparatory phase in machine learning, ensuring that datasets are suitably primed for model training and evaluation. One pivotal preprocessing technique aimed at ensuring equitable contribution of every feature to the analysis is standardization. Through the elimination of the mean and scaling to unit variance, the scikit-learn library\u0026apos;s StandardScaler class offers a straightforward method for standardizing features. Subsequently, the training set undergoes the fit transform technique, which computes the mean and standard deviation for each feature and normalizes the features based on these metrics. To maintain consistency in the preprocessing stages, the same procedure is applied to the testing set. By ensuring uniformity in the preprocessing steps, standardization prevents features with larger scales from exerting disproportionate influence during the model training process.\u003c/p\u003e\n\u003cp\u003eCurrently, the Random Forest Classifier model is being employed following the completion of model training and the implementation of various techniques to standardize the data. This widely acclaimed ensemble learning approach entails the construction of numerous decision trees and the aggregation of the mean forecast from each individual tree or the mode of the classes. By setting np.random.seed(42), the random seed was established as 42 to ensure the reproducibility of results. This fixed random seed facilitates the attainment of consistent outcomes in the random initialization of model parameters, thereby enabling the model to anticipate events on previously unseen instances. This is achieved through the fitting of the data and the discernment of underlying patterns and relationships within it, empowering the model with the capability to make informed predictions.\u003c/p\u003e\n\u003cp\u003eThe model\u0026apos;s performance was evaluated post-training using the score method on the testing data (X_test and y_test). This approach compares the predicted labels with the true labels in the testing set to ascertain the model\u0026apos;s accuracy. The accuracy score represents the percentage of correctly identified instances out of all examples in the testing set.\u003c/p\u003e\n\u003cp\u003eThe accuracy score obtained from the Random Forest Classifier is 53%, signifying the model\u0026apos;s ability to correctly classify 53% of instances within the testing set. Now, the K-Nearest Neighbors algorithm will be applied to the same dataset using the same trained model to assess its accuracy in comparison to the Random Forest Classifier.\u003c/p\u003e\n\u003cp\u003eThe accuracy score produced by the k-Nearest Neighbor Classifier is 89.4%, indicating its capability to correctly classify 89.4% of instances within the testing set. This accuracy surpasses that of the Random Forest Classifier, suggesting that the results yielded by the k-Nearest Neighbor model will likely be more precise than those obtained from the previous classifier. To ascertain if this algorithm has achieved the highest accuracy, the performance of another classifier, namely Logistic Regression, will be tested using the previously trained dataset.\u003c/p\u003e\n\u003cp\u003eUpon assessing the accuracy scores of the three algorithms, it has been determined that the K-Nearest Neighbor Classifier provides the most accurate predictions for heart patient data. To reinforce this conclusion, a confusion matrix will be utilized. This evaluation tool is instrumental in the performance assessment of machine learning classification problems. Serving as a table, the confusion matrix enables a comprehensive examination of how well an algorithm, typically a classifier, performs on a set of test data with known real values. It goes beyond simple accuracy measurements by providing insights into the model\u0026apos;s effectiveness in correctly and incorrectly identifying occurrences across multiple classes.\u003c/p\u003e\n\u003cp\u003eUpon evaluating the accuracy derived from the generated confusion matrix, it was found to be nearly identical for all three algorithms. To resolve this parity, an additional metric, \u0026quot;Recall,\u0026quot; has been incorporated into the matrix.\u003c/p\u003e\n\u003cp\u003eRecall, also known as sensitivity or true positive rate, serves as a pivotal performance indicator for classification models. It represents the percentage of true positive predictions, i.e., accurately predicted positive cases, among all actual positive instances. This metric addresses the question of how many of the actual positive situations were correctly predicted as positive by the model. Recall holds particular significance in scenarios where the omission of an illness (false negative) in a medical diagnosis can have serious ramifications. The primary objective is to minimize false negatives. While a high recall rate may lead to some false positives, it signifies the model\u0026apos;s effectiveness in identifying positive cases.\u003c/p\u003e\n\u003cp\u003eUpon incorporating this additional aspect into our evaluation, it is evident that the KNN model demonstrates a superior ability to predict the data more accurately, exhibiting a notably high recall rate.\u003c/p\u003e\n\u003cp\u003eAfter selecting the model, it is essential to examine the correlation between individuals with diabetes and heart disease. To achieve this, a correlation matrix has been constructed to provide insights into the likelihood of a person with diabetes also having heart disease.\u003c/p\u003e\n\u003cp\u003eThe correlation between diabetes and heart disease is a critical area of study, particularly considering the significant impact of these conditions on public health. Research indicates that over 70% of individuals over the age of 65 with diabetes are at risk of succumbing to some form of heart disease or stroke. Furthermore, patients with diabetes experience increased mortality following a myocardial infarction and have a poorer long-term prognosis with coronary artery disease. These findings underscore the intricate relationship between diabetes and cardiovascular health, emphasizing the need for comprehensive understanding and effective management of these conditions.\u003c/p\u003e\n\u003cp\u003eThe correlation matrix serves as a valuable tool in elucidating the relationship between diabetes and heart disease, shedding light on the percentage likelihood of an individual with diabetes also being affected by heart disease. This analysis is crucial for informing targeted interventions and healthcare strategies aimed at addressing the complex interplay between diabetes and heart disease.\u003c/p\u003e\n\u003cp\u003eAccording to the constructed correlation matrix, there is an approximately 17% association between diabetes and heart disease. While a positive correlation is evident, it is not particularly robust. Consequently, it can be inferred that an individual with diabetes faces a 17% probability of also being affected by heart disease.\u003c/p\u003e\n\u003cp\u003eThe scatter plot graph depicted above illustrates the relationship between heart disease and diabetes. As the presence of diabetes increases (moving up along the y-axis), the incidence of heart disease also increases (moving from left to right).\u003c/p\u003e\n\u003cp\u003eUnderstanding the correlation between diabetes and heart disease is crucial, given the significant health implications associated with these conditions. Research has shown that individuals with diabetes are at a heightened risk of developing cardiovascular complications, emphasizing the importance of comprehensively examining the relationship between these two health concerns.\u003c/p\u003e"},{"header":"5. Conclusion","content":"\u003cp\u003eThe analysis conducted underscores the pervasive threat of heart disease across diverse racial groups in the United States, with risk factors including smoking, high blood pressure, diabetes, high cholesterol, obesity, sedentary lifestyles, and excessive alcohol consumption. Leveraging data from the Behavioural Risk Factor Surveillance System (BRFSS), we have employed machine learning techniques like Random Forest, k-Nearest Neighbors (KNN), and Logistic Regression to predict heart disease occurrences. Notably, KNN emerges as the most accurate classifier among the models tested, demonstrating superior predictive capabilities.\u003c/p\u003e \u003cp\u003eAdditional insights garnered from confusion matrices and recall rates inform the selection of the most effective classification model. A correlation analysis reveals a moderate link of 17% between diabetes and heart disease, suggesting a nuanced understanding of their relationship. Visual representations, such as scatter plots, further elucidate the correlation between diabetes and heart disease, indicating a propensity for heart disease with increasing diabetes prevalence. These findings highlight the importance of leveraging advanced analytics to combat heart disease effectively, enabling targeted interventions and preventive strategies to mitigate its impact.\u003c/p\u003e"},{"header":"6. Future Perspectives of the Study","content":"\u003cp\u003eThe future perspective of this paper lies in the continued advancement and integration of healthcare analytics into routine clinical practice. As technology evolves and data analytics capabilities expand, the potential for even more precise risk assessment, personalized treatment strategies, and proactive interventions in diabetes management will grow. Additionally, the incorporation of artificial intelligence and machine learning algorithms can further enhance predictive modeling and decision-making processes, leading to more effective and efficient healthcare delivery.\u003c/p\u003e \u003cp\u003eFurthermore, the integration of wearable devices, remote monitoring technologies, and telemedicine solutions can facilitate real-time data collection and monitoring, enabling continuous feedback and personalized care for individuals with diabetes. Collaborations between healthcare providers, data scientists, and technology experts will be essential in driving innovation and optimizing the use of healthcare analytics for improved patient outcomes.\u003c/p\u003e \u003cp\u003eIn the future, the focus may shift towards developing comprehensive, integrated healthcare analytics platforms that seamlessly connect various data sources, streamline workflows, and empower both patients and healthcare providers with actionable insights. This holistic approach to data-driven healthcare management has the potential to revolutionize chronic disease care, enhance preventive measures, and ultimately contribute to better health outcomes for individuals with diabetes and other chronic conditions.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003eIt is being dispatched for exclusive consideration by the Journal and has not been sent elsewhere for publication.\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003eFunding: No funding was received for conducting this study.\u003c/li\u003e\n \u003cli\u003eCompeting interests: The authors have no competing interests to declare that are relevant to the content of this article.\u003c/li\u003e\n \u003cli\u003eEthics approval: Not applicable.\u003c/li\u003e\n \u003cli\u003eConsent to participate: Not applicable.\u003c/li\u003e\n \u003cli\u003eConsent for publication: Not applicable.\u003c/li\u003e\n \u003cli\u003eAvailability of data and materials: Not applicable.\u003c/li\u003e\n \u003cli\u003eCode availability: Not applicable.\u003c/li\u003e\n\u003c/ul\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eAbouelmehdi, K., Beni-Hessane, A., \u0026amp; Khaloufi, H. (2018). Big healthcare data: Preserving security and privacy. Journal of Big Data, 5(1), 1-18. https://doi.org/10.1186/s40537-017-0110-7\u003c/li\u003e\n \u003cli\u003eAlotaibi, Y. K., \u0026amp; Federico, F. (2017). The impact of health information technology on patient safety. Saudi Medical Journal, 38(12), 1173-1180. https://doi.org/10.15537/smj.2017.12.20631\u003c/li\u003e\n \u003cli\u003eAmerican College of Cardiology. (2021). Guideline-Directed Medical Therapy for Secondary Prevention of Myocardial Infarction. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2021/07/23/14/47/guideline-directed-medical-therapy-for-secondary\u003c/li\u003e\n \u003cli\u003eAmerican Diabetes Association. (2020). Cardiovascular disease and risk management: Standards of medical care in diabetes\u0026mdash;2020. Diabetes Care, 43(Supplement 1), S111-S134. https://doi.org/10.2337/dc20-S010\u003c/li\u003e\n \u003cli\u003eAmerican Diabetes Association. (2022). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u0026mdash;2022. Diabetes Care, 45(Supplement 1), S17\u0026ndash;S38.\u003c/li\u003e\n \u003cli\u003eAmerican Diabetes Association. (2022). Standards of medical care in diabetes\u0026mdash;2022. Diabetes Care, 45(Supplement 1), S1-S270. https://doi.org/10.2337/dc22-Sint\u003c/li\u003e\n \u003cli\u003eAmerican Heart Association. (2020). 2020 AHA guidelines for CPR and ECC. https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines\u003c/li\u003e\n \u003cli\u003eAmerican Heart Association. (2021). Lifestyle changes for heart attack prevention. https://www.heart.org/en/health-topics/heart-attack/lifestyle-changes-for-heart-attack-prevention\u003c/li\u003e\n \u003cli\u003eAmerican Heart Association. (2022). Life\u0026apos;s simple 7: Manage blood pressure. https://www.heart.org/en/healthy-living/healthy-lifestyle/my-life-check--lifes-simple-7/ls7--manage-blood-pressure\u003c/li\u003e\n \u003cli\u003eAnderson, L., Brown, J. P., Clark, A. M., Dalal, H., Rossau, H. K., Bridges, C., \u0026amp; Taylor, R. S. (2016). Patient education in the management of coronary heart disease. Cochrane Database of Systematic Reviews, 2016(6), CD008895. https://doi.org/10.1002/14651858.CD008895.pub3\u003c/li\u003e\n \u003cli\u003eAnderson, L., Oldridge, N., Thompson, D. R., Zwisler, A. D., Rees, K., Martin, N., ... \u0026amp; Taylor, R. S. (2016). Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews, 2016(1), CD001800.\u003c/li\u003e\n \u003cli\u003eBarnason, S., White-Williams, C., Rossi, L. P., Centeno, M., Crabbe, D. L., Lee, K. S., McCabe, N., Nauser, J., Schulz, P., Stamp, K., \u0026amp; Wood, K. (2017). Evidence for therapeutic patient education interventions to promote cardiovascular patient self-management: A scientific statement for healthcare professionals from the American Heart Association. Circulation: Cardiovascular Quality and Outcomes, 10(6), e000025. https://doi.org/10.1161/HCQ.0000000000000025\u003c/li\u003e\n \u003cli\u003eBarnason, S., Zimmerman, L., Young, L., \u0026amp; Schulz, P. (2017). Patient recovery after acute coronary syndrome: integrating the women\u0026apos;s recovery from myocardial inf\u003c/li\u003e\n \u003cli\u003eBates, D. W., Saria, S., Ohno-Machado, L., Shah, A., \u0026amp; Escobar, G. (2014). Big data in health care: Using analytics to identify and manage high-risk and high-cost patients. Health Affairs, 33(7), 1123-1131. https://doi.org/10.1377/hlthaff.2014.0041\u003c/li\u003e\n \u003cli\u003eBellamy, L., Casas, J. P., Hingorani, A. D., \u0026amp; Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet, 373(9677), 1773-1779. https://doi.org/10.1016/S0140-6736(09)60731-5\u003c/li\u003e\n \u003cli\u003eBenson, T., \u0026amp; Grieve, G. (2021). Principles of health interoperability: SNOMED CT, HL7 and FHIR. Springer Nature.\u003c/li\u003e\n \u003cli\u003eBhatt, D. L., \u0026amp; Mehta, C. (2020). Atherosclerosis in Diabetes Mellitus. In Diabetes Mellitus and Cardiovascular Disease (pp. 23-34). Springer, Cham.\u003c/li\u003e\n \u003cli\u003eBhatt, D. L., \u0026amp; Mehta, C. (2020). Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy. American Journal of Medicine, 133(8), 918-925.\u003c/li\u003e\n \u003cli\u003eBhatt, D. L., \u0026amp; Mehta, C. (2020). Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 36(5), 648-656. https://doi.org/10.1016/j.cjca.2019.12.033\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eBornfeldt, K. E., \u0026amp; Tabas, I. (2011). Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism, 14(5), 575-585. https://doi.org/10.1016/j.cmet.2011.07.015\u003c/li\u003e\n \u003cli\u003eBraunstein, M. L. (2018). Health informatics on FHIR: How HL7\u0026apos;s new API is transforming healthcare. Springer.\u003c/li\u003e\n \u003cli\u003eCenters for Disease Control and Prevention. (2021). Heart disease prevention. https://www.cdc.gov/heartdisease/prevention.htm\u003c/li\u003e\n \u003cli\u003eCensin, J. C., Peters, S. A. E., Bovijn, J., Ferreira, T., Pulit, S. L., M\u0026auml;gi, R., Mahajan, A., Holmes, M. V., \u0026amp; Lindgren, C. M. (2021). Causal relationships between obesity and the leading causes of death in women and men. PLoS Genetics, 15(10), e1008405. https://doi.org/10.1371/journal.pgen.1008405\u003c/li\u003e\n \u003cli\u003eChatterjee, S., Khunti, K., \u0026amp; Davies, M. J. (2020). Achieving glycaemic control with concentrated insulin in patients with type 2 diabetes. Drugs, 80(2), 119-129. https://doi.org/10.1007/s40265-019-01249-z\u003c/li\u003e\n \u003cli\u003eChow, C. K., Nguyen, T. N., Marschner, S., Diaz, R., Rahman, O., Avezum, A., Lear, S. A., Teo, K., Lanas, F., Yusoff, K., Yusuf, S., \u0026amp; Anand, S. S. (2020). Lifestyle and socioeconomic determinants of cardiovascular disease in South Asia: The PURE study. European Heart Journal, 41(33), 3163-3171. https://doi.org/10.1093/eurheartj/ehaa384\u003c/li\u003e\n \u003cli\u003eChow, C. K., Teo, K. K., Rangarajan, S., Islam, S., Gupta, R., Avezum, A., ... \u0026amp; Yusuf, S. (2020). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Jama, 310(9), 959-968.\u003c/li\u003e\n \u003cli\u003eContreras, I., \u0026amp; Vehi, J. (2018). Artificial intelligence for diabetes management and decision support: Literature review. Journal of Medical Internet Research, 20(5), e10775. https://doi.org/10.2196/10775\u003c/li\u003e\n \u003cli\u003eCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V.,\u0026nbsp;Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., Huikuri, H. V., Johansson, I., J\u0026uuml;ni, P., Lettino, M., Marx, N., Mellbin, L. G., \u0026Ouml;stgren, C. J., Rocca, B., Roffi, M., ... ESC Scientific Document Group. (2020). 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal, 41(2), 255-323. https://doi.org/10.1093/eurheartj/ehz486\u003c/li\u003e\n \u003cli\u003eCoventry, L., \u0026amp; Branley, D. (2018). Cybersecurity in healthcare: A narrative review of trends, threats and ways forward. Maturitas, 113, 48-52. https://doi.org/10.1016/j.maturitas.2018.04.008\u003c/li\u003e\n \u003cli\u003eDagliati, A., Marini, S., Sacchi, L., Cogni, G., Teliti, M., Tibollo, V., De Cata, P., Chiovato, L., \u0026amp; Bellazzi, R. (2018). Machine learning methods to predict diabetes complications. Journal of Diabetes Science and Technology, 12(2), 295-302. https://doi.org/10.1177/1932296817706375\u003c/li\u003e\n \u003cli\u003eDonath, M. Y., \u0026amp; Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11(2), 98-107. https://doi.org/10.1038/nri2925\u003c/li\u003e\n \u003cli\u003eEmerging Risk Factors Collaboration. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies.\u0026nbsp;Lancet, 375(9733), 2215-2222. https://doi.org/10.1016/S0140-6736(10)60484-9\u003c/li\u003e\n \u003cli\u003eFeldman, B., Martin, E. M., \u0026amp; Skotnes, T. (2016).\u0026nbsp;Big data in healthcare hype and hope. Dr. Bonnie 360. https://www.west-info.eu/files/big-data-in-healthcare.pdf\u003c/li\u003e\n \u003cli\u003eFrangogiannis, N. G. (2019). The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology, 16(1), 17-36. https://doi.org/10.1038/s41569-019-0185-2\u003c/li\u003e\n \u003cli\u003eGrundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1046-e1081. https://doi.org/10.1161/CIR.0000000000000624\u003c/li\u003e\n \u003cli\u003eHripcsak, G., Ryan, P. B., Duke, J. D., Shah, N. H., Park, R. W., Huser, V., Suchard, M. A., Schuemie, M. J., DeFalco, F. J., Perotte, A., Banda, J. M., Reich, C. G., Schilling, L. M., Matheny, M. E., Meeker, D., Pratt, N., \u0026amp; Madigan, D. (2015). Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Studies in Health Technology and Informatics, 216, 574-578. https://doi.org/10.3233/978-1-61499-564-7-574\u003c/li\u003e\n \u003cli\u003eHulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., \u0026amp; McKinney, E. F. (2020). From big data to precision medicine. Frontiers in Medicine, 6, 34. https://doi.org/10.3389/fmed.2019.00034\u003c/li\u003e\n \u003cli\u003eJiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., \u0026amp; Wang, Y. (2017). Artificial intelligence in healthcare: Past, present and future. Stroke and Vascular Neurology, 2(4), 230-243. https://doi.org/10.1136/svn-2017-000101\u003c/li\u003e\n \u003cli\u003eKalkman, S., van Delden, J., Banerjee, A., Tyl, B., Mostert, M., \u0026amp; van Thiel, G. (2019).\u0026nbsp;Patients\u0026apos; and public views and attitudes towards the sharing of health data for research: A narrative review of the empirical evidence. Journal of Medical Ethics, 0, 1-11. https://doi.org/10.1136/medethics-2019-105651\u003c/li\u003e\n \u003cli\u003eKaplan, B. (2016). How should health data be used? Privacy, secondary use, and big data sales. Cambridge Quarterly of Healthcare Ethics, 25(2), 312-329. https://doi.org/10.1017/S0963180115000614\u003c/li\u003e\n \u003cli\u003eKaur, G., \u0026amp; Sharma, A. (2021). Diabetic Cardiomyopathy: Mechanisms, Diagnosis, and Treatment. International Journal of Molecular Sciences, 22(16), 9006. https://doi.org/10.3390/ijms22169006\u003c/li\u003e\n \u003cli\u003eKruse, C. S., Goswamy, R., Raval, Y., \u0026amp; Marawi, S. (2016). Challenges and opportunities of big data in health care: A systematic review. JMIR Medical Informatics, 4(4), e38. https://doi.org/10.2196/medinform.5359\u003c/li\u003e\n \u003cli\u003eLehne, M., Sass, J., Essenwanger, A., Schepers, J., \u0026amp; Thun, S. (2019). Why digital medicine depends on interoperability. NPJ Digital Medicine, 2, 79. https://doi.org/10.1038/s41746-019-0158-1\u003c/li\u003e\n \u003cli\u003eLibby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524-533. https://doi.org/10.1038/s41586-021-03392-8\u003c/li\u003e\n \u003cli\u003eLysaght, T., Lim, H. Y., Xafis, V., \u0026amp; Ngiam, K. Y. (2019). AI-assisted decision-making in healthcare: The application of an ethics framework for big data in health and research. Asian Bioethics Review, 11(3), 299-314. https://doi.org/10.1007/s41649-019-00096-0\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eMancusi, C., Izzo, R., di Gioia, G., Losi, M. A., Barbato, E., \u0026amp; Morisco, C. (2020). Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Pressure \u0026amp; Cardiovascular Prevention, 27(6), 515-526. https://doi.org/10.1007/s40292-020-00408-8\u003c/li\u003e\n \u003cli\u003eMandel, J. C., Kreda, D. A., Mandl, K. D., Kohane, I. S., \u0026amp; Ramoni, R. B. (2016). SMART on FHIR:\u0026nbsp;Mandel, J. C., Kreda, D. A., Mandl, K. D., Kohane, I. S., \u0026amp; Ramoni, R. B. (2016).\u0026nbsp;SMART on FHIR: A standards-based, interoperable apps platform for electronic health records. Journal of the American Medical Informatics Association, 23(5), 899-908. https://doi.org/10.1093/jamia/ocv189\u003c/li\u003e\n \u003cli\u003eMurdoch, T. B., \u0026amp; Detsky, A. S. (2013).\u0026nbsp;The inevitable application of big data to health care.\u0026nbsp;JAMA, 309(13), 1351-1352. https://doi.org/10.1001/jama.2013.393\u003c/li\u003e\n \u003cli\u003eParikh, R. B., Kakad, M., \u0026amp; Bates, D. W. (2016).\u0026nbsp;Integrating predictive analytics into high-value care: The dawn of precision delivery. JAMA, 315(7), 651-652. https://doi.org/10.1001/jama.2015.19417\u003c/li\u003e\n \u003cli\u003ePiepoli, M. F., Hoes, A. W., Brotons, C., Hobbs, R. F. D., \u0026amp; Corra, U. (2020). Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Journal of General Practice, 24(1), 51-56. https://doi.org/10.1080/13814788.2017.1398320\u003c/li\u003e\n \u003cli\u003eRaghupathi, W., \u0026amp; Raghupathi, V. (2014). Big data analytics in healthcare: Promise and potential. Health Information Science and Systems, 2(1), 3. https://doi.org/10.1186/2047-2501-2-3\u003c/li\u003e\n \u003cli\u003eRistevski, B., \u0026amp; Chen, M. (2018). Big data analytics in medicine and healthcare. Journal of Integrative Bioinformatics, 15(3), 20170030. https://doi.org/10.1515/jib-2017-0030\u003c/li\u003e\n \u003cli\u003eShickel, B., Tighe, P. J., Bihorac, A., \u0026amp; Rashidi, P. (2018). Deep EHR: A survey of recent advances in deep learning techniques for electronic health record (EHR) analysis. IEEE Journal of Biomedical and Health Informatics, 22(5), 1589-1604. https://doi.org/10.1109/JBHI.2017.2767063\u003c/li\u003e\n \u003cli\u003eSiegel, E. R., Roybal, M. M., \u0026amp; Bennett, R. E. (2018).\u0026nbsp;Harnessing the power of data in health. Stanford Medicine 2018 Health Trends Report. https://med.stanford.edu/content/dam/sm/sm-news/documents/StanfordMedicineHealthTrendsWhitePaper2018.pdf\u003c/li\u003e\n \u003cli\u003e\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eSutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., \u0026amp; Kroeker, K. I. (2020).\u0026nbsp;An overview of clinical decision support systems: Benefits, risks, and strategies for success.\u0026nbsp;NPJ Digital Medicine, 3, 17. https://doi.org/10.1038/s41746-020-0221-y\u003c/li\u003e\n \u003cli\u003eTab\u0026aacute;k, A. G., Herder, C., Rathmann, W., Brunner, E. J., \u0026amp; Kivim\u0026auml;ki, M. (2012).\u0026nbsp;Prediabetes: A high-risk state for diabetes development. Lancet, 379(9833), 2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9\u003c/li\u003e\n \u003cli\u003eVerma, S., \u0026amp; Hussain, M. E. (2017).\u0026nbsp;Obesity and diabetes: An update. Diabetes \u0026amp; Metabolic Syndrome: Clinical Research \u0026amp; Reviews, 11(1), 73-79. https://doi.org/10.1016/j.dsx.2016.06.017\u003c/li\u003e\n \u003cli\u003eWorld Health Organization. (2021). Cardiovascular diseases. https://www.who.int/health-topics/cardiovascular-diseases\u003c/li\u003e\n \u003cli\u003eWorld Health Organization. (2021). Diabetes. https://www.who.int/health-topics/diabetes\u003c/li\u003e\n \u003cli\u003eZheng, Y., Ley, S. H., \u0026amp; Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), 88-98. https://doi.org/10.1038/nrendo.2017.151\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Heart disease, Diabetes, Predictive modelling, Risk factors, Artificial intelligence, Healthcare","lastPublishedDoi":"10.21203/rs.3.rs-4310669/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4310669/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eHeart disease is a significant global health concern characterized by the heart's inability to adequately pump blood, leading to symptoms like weakness, difficulty breathing, and swollen feet. Detecting heart disease early is crucial, often relying on factors such as age, gender, and pulse rate analysis, as well as electrocardiogram screenings for irregular heartbeats. Risk factors include obesity, smoking, diabetes, high blood pressure, and unhealthy diets, with diabetic individuals facing elevated risks due to accelerated atherosclerosis and high blood sugar levels. Managing heart disease involves lifestyle modifications, medication adherence, and regular medical check-ups. Healthcare systems utilize data mining, machine learning, and clinical decision support systems to analyze extensive databases and predict conditions like heart disease, employing techniques such as supervised and unsupervised learning. Big data applications in healthcare, incorporating genomics data and electronic health records, provide insights into treatment effectiveness and real-time patient data analysis, facilitating personalized medicine and potentially saving lives.\u003c/p\u003e \u003cp\u003eThis research paper assesses the various components found in diabetes patients\u0026rsquo; data to accurately forecast heart disease. It is identified by employing the Correlation-based Feature Subset Selection Technique with Best First Search, which is the most important characteristic for heart disease prediction. It has been discovered that age, gender, blood pressure diastolic, diabetes, smoking, obesity, diet, physical activity, stress, kind of chest pain, history of chest pain, troponin, ECG, and target are the most important factors for detecting heart disease. A variety of artificial intelligence methods are used and contrasted for cardiac disease, including logistic regression, K-nearest neighbor (K-NN), decision trees, random forests, and multilayer perceptrons (MLPs). Compared to using all the input features, K-NN with a subset of the features has the highest accuracy rate (80%).\u003c/p\u003e","manuscriptTitle":"Integrating Healthcare Analytics to Improve Diabetes Management and Prevent Heart Attacks: A Data-Driven Approach","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-05-09 18:09:06","doi":"10.21203/rs.3.rs-4310669/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"da890754-b1f4-4642-825d-c66be77c7b37","owner":[],"postedDate":"May 9th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2024-05-18T19:08:18+00:00","versionOfRecord":[],"versionCreatedAt":"2024-05-09 18:09:06","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4310669","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4310669","identity":"rs-4310669","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}